Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Design novel

In considering the applicability of preparative classical electrophoretic methods to chiral separations, it should be noted that practitioners in the art of classical electrophoresis have been particularly inventive in designing novel separation strategies. For instance, pH, ionic strength and density gradients have all been used. Isoelectric focusing and isotachophoresis are well-established separation modes in classical electrophoresis and are also being implemented in CE separations [7, 8]. These trends are also reflected in the preparative electrophoretic approaches discussed here. [Pg.289]

In this chapter the different transformations of the reactive site F will be dealt with separately. Due to the potential variability in the chemical nature of this second reactive site it was possible to combine a wide variety of chemically unlike monomers with each other thus designing novel block copolymers. [Pg.736]

Attaching some short peptidic sequences to adamantane makes it possible to design novel antagonists. The bradykinin antagonist, which is used as an anticancer agent, is an example. The adamantane-based peptidic bradykinin analog was utilized in strucmre-activity relationship (SAR) studies on the bradykinin receptors and showed a potent activity in inhibition of bradykinin-induced cytokine release and stimulation of histamine release [142]. [Pg.236]

We demonstrated that the morphology of nanostructures, electrochemical, and photoelectrochemical properties in the electrodes modified with nanodusters of Qo can be controlled by applying a strong magnetic field. The present study provides useful information for designing novel nanodevices whose photofunctions can be controlled by a magnetic field. [Pg.268]

Designing Novel Kinase Inhibitors from the NMR-based Screening of Fragments 27... [Pg.1]

DESIGNING NOVEL KINASE INHIBITORS FROM THE NMR-BASED SCREENING... [Pg.27]

The Shikimate pathway is responsible for biosynthesis of aromatic amino acids in bacteria, fungi and plants [28], and the absence of this pathway in mammals makes it an interesting target for designing novel antibiotics, fungicides and herbicides. After the production of chorismate the pathway branches and, via specific internal pathways, the chorismate intermediate is converted to the three aromatic amino acids, in addition to a number of other aromatic compounds [29], The enzyme chorismate mutase (CM) is a key enzyme responsible for the Claisen rearrangement of chorismate to prephenate (Scheme 1-1), the first step in the branch that ultimately leads to production of tyrosine and phenylalanine. [Pg.4]

The first example of a donor-acceptor molecular complex was noted in 1949 by Bensei and Hildebrand [137] in their studies involving charge transfer complexes between benzene and molecular iodine. Subsequently such complexes were studied by Mulliken [138] and now more recently have been used by Stoddart et al. [16,139] in designing novel self-assembling systems. [Pg.58]

The recent progress surveyed in this review shows the promise that late transition metal catalysts can provide in the production of new materials. We will continue our exploration of new catalyst design for the synthesis of new functional materials with unconventional topologies. Given the unique features of late transition-metal polymerization catalysts and further improvement in catalyst stability and activity for copolymerization with polar comonomers, the future of designing novel functional polymeric materials with late-transition-metal catalysts is very promising. [Pg.216]

In models of MND, therapeutic manipulations, manipulation of expression of selected genes in specific cell populations [15, 16], creation of chimeric animals to test whether abnormalities are cell autonomous [17], administration of trophic factors to prevent trophic cell death [18-20] and testing of a variety of drug therapies [21-24] have been used to try to ameliorate phenotypes and thus provide insights into disease mechanisms and potential treatment strategies [1, 3, 4, 15, 25, 26]. Results of these studies are being used to design novel therapies to be tested in clinical trials in humans. [Pg.732]

The connection between anomalous conductivity and anomalous diffusion has been also established(Li and Wang, 2003 Li et al, 2005), which implies in particular that a subdiffusive system is an insulator in the thermodynamic limit and a ballistic system is a perfect thermal conductor, the Fourier law being therefore valid only when phonons undergo a normal diffusive motion. More profoundly, it has been clarified that exponential dynamical instability is a sufRcient(Casati et al, 2005 Alonso et al, 2005) but not a necessary condition for the validity of Fourier law (Li et al, 2005 Alonso et al, 2002 Li et al, 2003 Li et al, 2004). These basic studies not only enrich our knowledge of the fundamental transport laws in statistical mechanics, but also open the way for applications such as designing novel thermal materials and/or... [Pg.11]

These structures are currently guiding a number of laboratories in their attempt to design novel, more selective Src kinase inhibitors. [Pg.6]

Regan, L. (1995) Protein design novel metal-binding sites. Trends Biochem. Sci. 20,280-285. [Pg.211]

The process of combining cyanine and squaraine dyes by encapsulation, or covalent or noncovalent attachment with macrocyclic hosts, macromolecules, and micro- or nano-particles is a promising way to design novel probes and labels with substantially improved properties and for the development of advanced fluorescence-based assays. Nevertheless, the physicochemical properties of these dye-compositions are strongly dependent on the dye structure as well as the nature of the host macrocycle, macromolecule, or particle. Finally, development of new methods to synthesize these tracers can also be considered a challenging task. [Pg.185]

Parrill AL, Reddy MR. Rational Drug Design—Novel Methodology and Practical Applications, American Chemical Society, Washington, DC, 1999. [Pg.92]

Jones, G., Willett, P, Glen, R. C., Leach, A. R. and Taylor, R., 1999, Rational Drug Design, Novel Methods and Practical Applications. ACS Symposium Series 719, 271-291. [Pg.44]

Structure-activity relationships are very important in understanding drug actions and in designing novel drugs. Seemingly small modifications in a drug s molecular structure can radically alter its effects. [Pg.80]

Teopsha, a., Cho, S.)., Zheng, W. New Tricks for an Old Dog development and application of novel QSAR methods for rational design of combinatorial chemical libraries and database mining. In Rational Drug Design Novel Methodology and Practical Applications, ACS Symposium Series Vol. 719, Paeeill,... [Pg.453]

Designing Novel Tioi-Based Gold Catalysts with Improved Performance... [Pg.239]


See other pages where Design novel is mentioned: [Pg.352]    [Pg.155]    [Pg.125]    [Pg.110]    [Pg.37]    [Pg.49]    [Pg.244]    [Pg.189]    [Pg.274]    [Pg.75]    [Pg.343]    [Pg.91]    [Pg.119]    [Pg.131]    [Pg.91]    [Pg.153]    [Pg.377]    [Pg.348]    [Pg.382]    [Pg.158]    [Pg.516]    [Pg.59]    [Pg.125]    [Pg.395]    [Pg.126]    [Pg.255]    [Pg.43]    [Pg.10]    [Pg.119]   
See also in sourсe #XX -- [ Pg.3 ]




SEARCH



© 2024 chempedia.info